FDA Inspection
King Bio Inc.King Bio Inc. – FDA Inspection, Jul 20, 2018
Record Details
This FDA Inspection record concerns King Bio Inc., with an inspection on July 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Melanie M. Walker
- Rachael L. Derby (Issuing Officer)
- Sonya M. Edmonds (FDA Associated Person)
View Company Profile
ID · db39b8b3-2074-480f-ba35-fa6fc5a72646
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1059419
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
Other FDA inspections of King Bio Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 28, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 2, 2017 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| September 4, 2015 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| October 15, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for King Bio Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.